The proton pump inhibitor (PPI) test in GERD - Does it still have a role?

被引:32
作者
Gasiorowska, Anita
Fass, Ronnie
机构
[1] So Arizona VA Hlth Care Syst, Dept Med, Gastroenterol Sect, Clin Res Grp, Tucson, AZ USA
[2] Arizona Hlth Sci Ctr, Tucson, AZ 85724 USA
关键词
gastroesophageal reflux disease; noncardiac chest pain; proton pump inhibitor; PPI test; erosive esophagitis; nonerosive reflux disease; extraesophageal manifestations of GERD;
D O I
10.1097/MCG.0b013e31816c47ed
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The proton pump inhibitor (PPI) test is a short course of high-dose PPI, used to diagnose gastroesophageal reflux disease (GERD). This diagnostic strategy is commonly used globally, primarily because of its availability, simplicity, and high sensitivity. The PPI test hits been proven to be a sensitive tool for diagnosing GERD in noncardiac chest pain patients and in preliminary trials in extraesophageal manifestations of GERD. Several recent meta-analyses reevaluated the value Of the PPI test in patients with classic GERD-related symptoms and noncardiac chest pain. Although the results were conflicting, the PPI test remains a popular tool for determining the presence of GERD. Attempts to challenge the PPI test without offering attractive alternatives are unlikely to alter clinical practice.
引用
收藏
页码:867 / 874
页数:8
相关论文
共 60 条
[1]
Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care [J].
Aanen, M. C. ;
Weusten, B. L. A. M. ;
Numans, M. E. ;
De Wit, N. J. ;
Baron, A. ;
Smout, A. J. P. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (09) :1377-1384
[2]
Bate CM, 1999, ALIMENT PHARM THERAP, V13, P59
[3]
The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial [J].
Bautista, J ;
Fullerton, H ;
Briseno, M ;
Cui, H ;
Fass, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (10) :1123-1130
[4]
BEHAR J, 1976, GASTROENTEROLOGY, V71, P9
[5]
Effect of omeprazole in patients with chest pain and normal coronary anatomy: Initial experience [J].
Chambers, J ;
Cooke, R ;
Anggiansah, A ;
Owen, W .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1998, 65 (01) :51-55
[6]
Clouse RE, 1999, GUT, V45, P31
[7]
Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: A metaanalysis [J].
Cremonini, F ;
Wise, J ;
Moayyedi, P ;
Talley, NJ .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (06) :1226-1232
[8]
*DEGN ASS INC, 2006, ROM, V3
[9]
Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain [J].
Dekel, R ;
Martinez-Hawthorne, SD ;
Guillen, RJ ;
Fass, R .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (01) :24-29
[10]
The role of proton pump inhibitors in gastro-oesophageal reflux disease [J].
Dekel, R ;
Morse, C ;
Fass, R .
DRUGS, 2004, 64 (03) :277-295